Clinical trial to test efficacy and tolerability of minocycline (tetracycline antibiotic), over the course of two years, in disease modification of Alzheimer's disease.
Clinical trial (phase 3) to test efficacy and safety of daily oral masitinib, over the course of 24 weeks, in the treatment of patients with mild-moderate Alzheimer’s Disease.
AD Genetics studies genetic contributions of early-onset Alzheimer’s Disease (onset pre-65 years) to inform molecular biology, epidemiology, biomarker and clinical research.
Time for dementia is an educational programme where medical, nursing and paramedic students from University of Surrey will be visiting a family affected by dementia. The overall aim is to improve student knowledge, attitudes and empathy towards people with dementia and their care-givers.
This study will be the biggest of its kind and aims to improve the lives of people with dementia - and their carers - by looking at how smart technology placed in the homes of people with dementia can allow clinicians to remotely monitor someone's health and take prompt support if they begin to become unwell.
This is a randomized, double blind study that looks at the results of using crenezumab in people with prodromal to mild Alzheimer's disease.